We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-13.38%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$21.9B
AUM Growth
-$2.87B
(-12%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
4.59%
Top 10 Holdings %
Top 10 Hldgs %
35.4%
Holding
106
New
15
Increased
33
Reduced
21
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$655M |
| 2 |
American International
AIG
|
+$587M |
| 3 |
McKesson
MCK
|
+$520M |
| 4 |
XYZ
Block Inc
XYZ
|
+$471M |
| 5 |
Intuit
INTU
|
+$462M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$659M |
| 2 |
T-Mobile US
TMUS
|
+$554M |
| 3 |
GE Aerospace
GE
|
+$316M |
| 4 |
Match Group
MTCH
|
+$298M |
| 5 |
XP
XP
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.66% |
| 2 | Financials | 21.95% |
| 3 | Technology | 15.34% |
| 4 | Communication Services | 9.63% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zai Lab
ZLAB
$2.92B
| $114M | 0.52% |
3,299,598
+166,301
| +5% | +$5.86M |
|
52
Insulet
PODD
$10B
| $110M | 0.5% |
503,401
-43,986
| -8% | -$10M |
|
53
Inspire Medical Systems
INSP
$1.71B
| $109M | 0.5% |
595,193
+284,312
| +91% | +$56.7M |
|
54
Progressive
PGR
$123B
| $105M | 0.48% |
901,744
-135,562
| -13% | -$15.4M |
|
55
CME Group
CME
$93.2B
| $104M | 0.48% |
+508,639
| New | +$108M |
|
56
Western Digital
WDC
$151B
| $88.2M | 0.4% |
+2,601,515
| New | +$104M |
|
57
RH
RH
$3.46B
| $85.2M | 0.39% |
+401,230
| New | +$119M |
|
58
Micron Technology
MU
$981B
| $81.3M | 0.37% |
+1,470,600
| New | +$99.9M |
|
|
COUP
59
DELISTED
Coupa Software Incorporated
COUP
| $80.8M | 0.37% |
+1,414,833
| New | +$109M |
|
60
Ginkgo Bioworks
DNA
$506M
| $64.5M | 0.29% |
677,103
-599,276
| -47% | -$73.1M |
|
61
Celldex Therapeutics
CLDX
$3.48B
| $63M | 0.29% |
2,337,854
+491,207
| +27% | +$14.3M |
|
62
Global E Online
GLBE
$6.86B
| $61.4M | 0.28% |
3,044,726
-2,083,722
| -41% | -$47.9M |
|
|
INBX
63
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $60.2M | 0.28% |
5,305,866
| – | – |
|
64
Zentalis Pharmaceuticals
ZNTL
$295M
| $56.9M | 0.26% |
2,026,656
| – | – |
|
65
Pharvaris
PHVS
$2.41B
| $55.1M | 0.25% |
2,491,923
+11,604
| +0.5% | +$216K |
|
|
SWAV
66
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $54.3M | 0.25% |
+284,000
| New | +$50.1M |
|
67
Procept Biorobotics
PRCT
$1.31B
| $50.5M | 0.23% |
1,545,000
-2,113,892
| -58% | -$76.9M |
|
68
Rivian
RIVN
$23.7B
| $41.2M | 0.19% |
1,602,193
-1,602,196
| -50% | -$50M |
|
69
Avis
CAR
$4.97B
| $41M | 0.19% |
+278,673
| New | +$61.1M |
|
|
OHPAU
70
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $36.3M | 0.17% |
3,703,693
-85,081
| -2% | -$835K |
|
|
DAWN
71
DELISTED
Day One Biopharmaceuticals
DAWN
| $33.2M | 0.15% |
1,857,424
+700,000
| +60% | +$7.23M |
|
72
Las Vegas Sands
LVS
$29.6B
| $32.4M | 0.15% |
+964,915
| New | +$33.4M |
|
73
Rallybio
RLYB
$87M
| $31.7M | 0.14% |
524,347
| – | – |
|
74
4D Molecular Therapeutics
FDMT
$600M
| $27.5M | 0.13% |
3,937,914
| – | – |
|
|
KNTE
75
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $23M | 0.11% |
1,820,462
| – | – |
|
Similar funds
SAM
VIA
Viking Global Investors's Q2 2022 Portfolio in Review
As of Q2 2022, Viking Global Investors held 106 positions worth $21.9B, down 12% from $24.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Viking Global Investors deployed $1B of net new capital in Q2 2022, opening 15 new positions and adding to 33 existing holdings. Its largest new stake was American International: 10,108,715 shares worth $517M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was T-Mobile US, an estimated $554M trimmed.
- Viking Global Investors's largest Q2 2022 buy was American International: 10,108,715 shares worth $517M.
- Viking Global Investors added most to Elevance Health in Q2 2022, an estimated $655M increase.
- Viking Global Investors's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $554M.
- Viking Global Investors fully exited Comcast in Q2 2022, selling an estimated $659M.
- Viking Global Investors's ten largest holdings make up 35% of its $21.9B portfolio in Q2 2022.
- Viking Global Investors opened 15 new positions and closed 24 in Q2 2022.
- Viking Global Investors's portfolio value fell 12% quarter-over-quarter to $21.9B.
Based on Viking Global Investors's 13F filing for Q2 2022, filed 15 Aug 2022.